IBB

The iShares Biotechnology ETF (IBB) invests in equity securities of companies classified in the biotechnology sub‑industry, primarily U.S.‑listed firms that develop and commercialize therapeutic drugs, diagnostics and related life‑science tools, with a modest amount of exposure to international biotech firms. The fund seeks to track the performance of the NYSE (or Nasdaq) Biotechnology Index by holding a market‑capitalisation‑weighted basket of over one hundred biotech and life‑science companies. It provides broad sector exposure rather than focusing on a few large names, spreading holdings across large, mid and small‑cap biotech stocks. IBB is suited to growth‑oriented investors who want concentrated exposure to the biotechnology industry and are comfortable with the higher volatility that typically accompanies the sector.